Effects of Different Exercises on Energy Metabolism and Muscle Activation in Normal-Weight and Overweight Students

August 28, 2025 updated by: Haiwei Li, Shanxi Normal University

This clinical trial aims to investigate the effects of different exercise modalities on energy metabolism and muscle activation in both normal-weight and overweight university students.

The main question it aims to answer is:

Compared to normal-weight university students, does slow jogging at different step frequencies reduce body weight and increase energy expenditure (and metabolic rate) in overweight university students? Compared to normal-weight university students, does slow jogging at different step frequencies enhance muscle activation effects in overweight university students?

Researchers will compare three distinct step frequencies during slow jogging (162, 180, and 198 steps per minute) to determine which exercise modality is potentially more effective for increasing energy expenditure and metabolic rate.

Participants will:

Participants will sequentially undergo three separate testing sessions, each involving ultra-slow running at one of the three step frequencies (162, 180, or 198 steps per minute).

Testing sessions will occur once per week in the laboratory.

Study Overview

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanxi
      • Taiyuan, Shanxi, China, 030031
        • Shanxi Normal University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Aged 18 to 23 years old;
  2. BMI between 24.0 kg/m² and 27.9 kg/m² ;
  3. No participation in any structured weight loss or weight control interventions (including exercise programs, pharmacological agents, or dietary regimens) within the preceding three months;
  4. Cleared for exercise participation with no identified risks, as determined by the Physical Activity Readiness Questionnaire (PAR-Q);
  5. Willing and able to comply fully with the experimental protocol, including completion of all training sessions and required measurements;
  6. Provision of written informed consent.

Exclusion Criteria:

  1. History of psychiatric disorders, diabetes mellitus, heart disease, hypertension, anemia, or any other contraindications to exercise (e.g., dizziness, chest pain, shortness of breath);
  2. Immune dysfunction or severe hepatic or renal insufficiency;
  3. Unhealthy habits, such as regular smoking or excessive alcohol consumption;
  4. Current use of prescription medication (excluding contraceptives or incidental short-term medications, if specified and approved by the study investigators);
  5. Coagulation disorders or a significant bleeding tendency.

Withdrawal and Termination Criteria:

  1. Voluntary withdrawal from the study or discontinuation for any other reason;
  2. Poor compliance, defined as failure to follow instructions or complete assigned tasks as required by the protocol;
  3. Experiencing severe exercise intolerance or adverse reactions to the intervention.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Step frequency group 1

Participants will receive step frequency in the following order:

First test: 162 steps per minute; Second test: 180 steps per minute; Third test: 198 steps per minute.

The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 162 steps per minute crossover to 180 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 180 steps per minute crossover to 162 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 198 steps per minute crossover to 162 steps per minute and 180 steps per minute.
Experimental: Step frequency group 2

Participants will receive step frequency in the following order:

First test: 162 steps per minute; Second test: 198 steps per minute; Third test: 180 steps per minute.

The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 162 steps per minute crossover to 180 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 180 steps per minute crossover to 162 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 198 steps per minute crossover to 162 steps per minute and 180 steps per minute.
Experimental: Step frequency group 3
Participants will receive step frequency in the following order: First test: 180 steps per minute; Second test: 162 steps per minute; Third test: 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 162 steps per minute crossover to 180 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 180 steps per minute crossover to 162 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 198 steps per minute crossover to 162 steps per minute and 180 steps per minute.
Experimental: Step frequency group 4

Participants will receive step frequency in the following order:

First test: 180 steps per minute; Second test: 198 steps per minute; Third test: 162 steps per minute.

The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 162 steps per minute crossover to 180 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 180 steps per minute crossover to 162 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 198 steps per minute crossover to 162 steps per minute and 180 steps per minute.
Experimental: Step frequency group 5

Participants will receive step frequency in the following order:

First test: 198 steps per minute; Second test: 162 steps per minute; Third test: 180 steps per minute.

The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 162 steps per minute crossover to 180 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 180 steps per minute crossover to 162 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 198 steps per minute crossover to 162 steps per minute and 180 steps per minute.
Experimental: Step frequency group 6

Participants will receive step frequency in the following order:

First test: 198 steps per minute; Second test: 180 steps per minute; Third test: 162 steps per minute.

The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 162 steps per minute crossover to 180 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 180 steps per minute crossover to 162 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running. 198 steps per minute crossover to 162 steps per minute and 180 steps per minute.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resting Energy Expenditure (REE)
Time Frame: Baseline
Subjects abstained from strenuous activity, substances (medication/alcohol/caffeine), and smoking 24h pre-test; females avoided menstruation. Post 12h fast/sleep, subjects rested seated 15min. Resting HR measured (Polar RS400). Subjects fitted with cardiopulmonary telemetry (Cortex Metamax 3B), positioned supine. Maintained steady breathing, upward gaze, minimal movement. HR/V̇O₂ monitored until stabilization. 10min data collection; steady state = <5% V̇O₂ fluctuation over 5min.
Baseline
Energy Expenditure at Step Frequencies
Time Frame: through study completion, an average of 4 weeks
Telemetry/HR monitor worn for 3min warm-up. First test: 10min treadmill run (5 km/h) with HR/V̇O₂ recording. Two subsequent sessions followed. Randomized crossover prevented order effects: subjects drew lots for step frequency sequence (162, 180, 198 steps/min). Metronome ensured adherence.
through study completion, an average of 4 weeks
Heart rate
Time Frame: through study completion, an average of 4 weeks
Upon entering the laboratory, subjects wore a heart rate telemetry monitor (RS400 Polar, Finland) and rested seated for 15 minutes to obtain resting heart rate. Following warm-up, subjects commenced testing. A heart rate monitor was secured on the right wrist pre-exercise to continuously monitor heart rate during activity.
through study completion, an average of 4 weeks
Electromyographic indicators
Time Frame: through study completion, an average of 4 weeks
Wireless surface EMG data were acquired using the Trigno system (Delsys®, USA) at 2000 Hz. Electrodes were positioned at the mid-belly of each muscle parallel to the muscle fiber orientation. Signals were recorded from the:Biceps femoris、Rectus femoris、Tibialis anterior、Lateral gastrocnemius、Medial gastrocnemius. EMGworks Analysis® software (Delsys) processed raw signals.
through study completion, an average of 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-Exercise Oxygen Consumption (EPOC)
Time Frame: through study completion, an average of 4 weeks
EPOC was calculated from pre-/post-exercise oxygen consumption (O₂PRE/O₂POST) measured via portable cardiopulmonary telemetry (Cortex Metamax 3B): EPOC (L) = O₂POST (L) - O₂PRE (L) where: EPOC denotes excess post-exercise oxygen consumption, O₂POST represents post-exercise oxygen consumption, and O₂PRE represents pre-exercise oxygen consumption.
through study completion, an average of 4 weeks
Fat Oxidation
Time Frame: through study completion, an average of 4 weeks
Fat Oxidation Data were collected and analyzed using the portable cardiopulmonary telemetry system (Cortex Metamax 3B, Germany). The fat oxidation rate was calculated as follows: Fat oxidation rate (g/min) = ② Fat Oxidation Fat oxidation rate was derived as: 1.695 × V̇O₂ (L/min) - 1.701 × V̇CO₂ (L/min) (g/min) using mean V̇O₂/V̇CO₂ from final 2min of each stage. ③ Carbohydrate Oxidation Carbohydrate oxidation rate was calculated as: 4.585 × V̇CO₂ (L/min) - 3.226 × V̇O₂ (L/min) (g/min) using mean V̇O₂/V̇CO₂ from final 2min of each stage. All data collected/analyzed with Cortex Metamax 3B system.
through study completion, an average of 4 weeks
Carbohydrate Oxidation
Time Frame: through study completion, an average of 4 weeks
Carbohydrate oxidation rate was calculated as: 4.585 × V̇CO₂ (L/min) - 3.226 × V̇O₂ (L/min) (g/min) using mean V̇O₂/V̇CO₂ from final 2min of each stage. All data collected/analyzed with Cortex Metamax 3B system.
through study completion, an average of 4 weeks
RPE
Time Frame: through study completion, an average of 4 weeks
Immediately after each exercise stage, subjects rated perceived exertion using the Borg RPE scale. The 15-point scale (6-20; 6 = no exertion, 20 = maximal exertion) was administered and recorded post-stage.
through study completion, an average of 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2025

Primary Completion (Actual)

July 15, 2025

Study Completion (Actual)

July 21, 2025

Study Registration Dates

First Submitted

August 8, 2025

First Submitted That Met QC Criteria

August 28, 2025

First Posted (Estimated)

August 29, 2025

Study Record Updates

Last Update Posted (Estimated)

August 29, 2025

Last Update Submitted That Met QC Criteria

August 28, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2025-0505

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Energy Expenditure

Clinical Trials on 162 step frequency

Subscribe